AAM Sees ‘Red Flag’ In IQVIA Biosimilars Report
US Association’s Biosimilars Council Cautions Over Long-Term Market Sustainability
While the latest IQVIA data points to accelerated uptake of US biosimilars over the next five years, with associated increases in spending and savings, local off-patent industry association the AAM says the report raises a “red flag” over long-term market sustainability.
